Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
(2) Dr. Syed A. A. Rizvi, Nova Southeastern University, USA.
(3) Dr. Giuseppe Murdaca, University of Genoa, Italy.
Reviewers:
(1) Muhammad Tahir, Islamia College University Peshawar, Pakistan.
(2) Vinod Nikhra, Hindu Rao Hospital & NDMC Medical College, India.
(3) Hossein Salmanizadeh, Institute of Biochemistry and Biophysics, University of Tehran, Iran.
(4) Ellen Ayepa, Sichuan Agricultural University, China.
Additional Reviewers:
(1) Ishtiaq Ahmed, Al-Nafees Medical College, Isra University, Pakistan.
(2) Wagner Quintilio, Institute Butantan, Brazil.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 6.75/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Muhammad Tahir, Pakistan) | File 1 | NA
Stage 2 | Peer review report_2 (Vinod Nikhra, India) | File 1 | NA
Stage 2 | Peer review report_3 (Hossein Salmanizadeh, Iran) | File 1 | File 2
Stage 2 | Peer review report_4 (Ellen Ayepa, China)| File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA
Stage 3 | Comment_Editor_3_v1 | File 1 | NA